Hypertrophic cardiomyopathy classification and nomenclature require a conceptual revision to resolve ambiguities that negatively impact accurate diagnosis and clinical management.
Absolute Event Rate: 0% vs 0%
2] This ambiguity has had, in turn, substantial impact on accurate diagnosis, full understanding of disease expression, and ultimately, decisions regarding management. At this juncture, it would seem appropriate and timely to conceptually revisit and clarify this important issue of names, consistent with the evolving knowledge of the cardiomyopathies.
Maron et al. (Sun,) reported a other. Hypertrophic cardiomyopathy classification and nomenclature require a conceptual revision to resolve ambiguities that negatively impact accurate diagnosis and clinical management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: